Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Mr. Yu Jin as Executive Director and A Member of Competition Executive Committee
the Company, has been appointed as an executive director and a member of competition executive committee of the Company with effect from 20 October 2023. Yu Jin, aged 54, has been appointed as the chief executive officer of the Company on 19 April 2023. Mr. Yu has more than 30 years of experience in medical and pharmaceutical industry. Mr. Yu was an assistant to the chairman of the board of directors in Tianda Pharmaceuticals Limited (stock code: 0455) from 2022 to February 2023 and served as the managing director in Beiyu Medical Device (Shanghai) Co. Ltd. from 2016 to 2022. Mr. Yu held senior positions such as general manager of the PRC region in different well-known multinational medical and pharmaceutical companies including Abbott's Diabetes Care Division, Johnson & Johnson Vision, Gambro and BSN Medical. Mr. Yu obtained a bachelor's degree in industrial foreign trading from Guangdong Institute of Technology (now known as Guangdong University of Technology) in 1991 and obtained EMBA degree from China Europe International Business School in 2011.